Cognitive decline can vary widely, from mild memory lapses to severe dementia, which can significantly disrupt daily life. Alzheimer’s disease is...
Vous n'êtes pas connecté
Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.
Cognitive decline can vary widely, from mild memory lapses to severe dementia, which can significantly disrupt daily life. Alzheimer’s disease is...
People with type 2 diabetes are at increased risk of Alzheimer's disease and other adverse cognitive health issues.
MONDAY, Aug. 12, 2024 -- For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent...
WEDNESDAY, Aug. 7, 2024 -- For individuals newly diagnosed with type 2 diabetes mellitus (T2DM), both short and long sleep duration are associated...
Researchers from Thomas Jefferson University have found that a combination of two diabetes drugs, dapagliflozin and exenatide, continues to...
A new study has revealed that both short and long sleep durations are linked to microvascular disease in individuals newly diagnosed with type 2...
Lawyer and author Albert Gyamfi says that healthcare professionals have a responsibility to inform their patients about the potential side effects of...
A recent study published in JAMA Network Open has revealed that maintaining stable blood sugar levels within personalized target ranges may help...
Metformin is a well-known medication primarily prescribed to manage blood sugar levels in people with diabetes. It works by improving the body’s...
While there is no guaranteed way to prevent it, engaging in certain activities can significantly reduce the risk of getting dementia. Dementia is one...